Abstract
A long-standing and intriguing question in the cell biology field has been ‘how are double-strand DNA breaks (DSBs) created and repaired during mitosis in human cells?’ It is now clear from several studies that DSBs do occur in mitotic cells, but it remains unclear whether the cellular response to DSBs is different in mitosis from that in interphase. Previously, mitotic cells have been shown to stabilize DSBs until they can be repaired in the subsequent cell cycle {1-4}, and that MDC1 and TOPBP1 are recruited by an unknown mechanism to mitotic DSBs {5}. In this article, Zompit et al. have resolved the above puzzle by demonstrating that CIP2A (cancerous inhibitor of protein phosphatase 2A) and TOPBP1 need to form a ternary complex with MDC1 to be efficiently recruited to DSB sites in mitosis. They also showed that CIP2A’s interaction TOBP1 at DSB sites only occurs in mitosis via a nuclear exclusion mechanism during interphase. These findings provide new evidence on the stabilization of DSB sites in mitosis via the CIP2A-TOPBP1 complex, which then promotes their repair in the next cell cycle. Considering that cancer cells have elevated mitotic defects due to elevated replication stress (caused largely by oncogene activation and defective checkpoints), CIP2A-TOPBP1-mediated DSB stabilization could potentially be a therapeutic target in cancer.